These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30451320)

  • 1. Evaluation of medical and surgical treatments for hidradenitis suppurativa using real-life data from the Scandinavian registry (HISREG).
    Grimstad Ø; Tzellos T; Dufour DN; Bremnes Ø; Skoie IM; Snekvik I; Jarnaess E; Kyrgidis A; Ingvarsson G
    J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):1164-1171. PubMed ID: 30451320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
    Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
    Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world effectiveness and safety of the LAight-therapy in patients with hidradenitis suppurativa.
    Strobel A; Schultheis M; Staubach P; Grabbe S; Mann C; Hennig K; Szepietowski JC; Matusiak L; Krajewski P; von Stebut E; Garcovich S; Bayer H; Heise M; Podda M; Kirschner U; Nikolakis G
    J Dtsch Dermatol Ges; 2024 Jul; 22(7):936-945. PubMed ID: 38807028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort.
    van Straalen KR; Tzellos T; Alavi A; Benhadou F; Cuenca-Barrales C; Daxhelet M; Daoud M; Efthymiou O; Giamarellos-Bourboulis EJ; Guillem P; Gulliver W; Jemec GBE; Katoulis A; Koenig A; Lazaridou E; Lowes MA; Marzano AV; Matusiak L; Molina-Leyva A; Moltrasio C; Pinter A; Potenza C; Prens EP; Romaní J; Saunte DM; Sayed C; Skroza N; Stergianou D; Szepietowski JC; Trigoni A; Vilarrasa E; Kyrgidis A; Zouboulis CC; van der Zee HH
    Dermatology; 2023; 239(3):362-367. PubMed ID: 36630943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Results from Period A of RELIEVE, a Multicenter Randomized, Controlled Trial.
    Schultheis M; Staubach P; Nikolakis G; Grabbe S; Ruckes C; von Stebut E; Kirschner U; Matusiak Ł; Szepietowski JC
    Dermatology; 2022; 238(3):476-486. PubMed ID: 34535610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
    Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
    Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized controlled trial assessing the efficacy of adjunctive hyperbaric oxygen therapy in the treatment of hidradenitis suppurativa.
    Yildiz H; Senol L; Ercan E; Bilgili ME; Karabudak Abuaf O
    Int J Dermatol; 2016 Feb; 55(2):232-7. PubMed ID: 26267600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging medical treatments for hidradenitis suppurativa.
    Lyons AB; Shabeeb N; Nicholson CL; Braunberger TL; Peacock A; Hamzavi IH
    J Am Acad Dermatol; 2020 Aug; 83(2):554-562. PubMed ID: 32289386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa.
    Chiricozzi A; Faleri S; Franceschini C; Caro RD; Chimenti S; Bianchi L
    Wounds; 2015 Oct; 27(10):258-64. PubMed ID: 26479209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients.
    Join-Lambert O; Coignard-Biehler H; Jais JP; Delage M; Guet-Revillet H; Poirée S; Duchatelet S; Jullien V; Hovnanian A; Lortholary O; Nassif X; Nassif A
    J Antimicrob Chemother; 2016 Feb; 71(2):513-20. PubMed ID: 26565016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): Retrospective analysis of 74 patients.
    Posch C; Monshi B; Quint T; Vujic I; Lilgenau N; Rappersberger K
    J Am Acad Dermatol; 2017 Jul; 77(1):123-129.e5. PubMed ID: 28377030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation.
    Caposiena Caro RD; Molinelli E; Brisigotti V; Offidani A; Bianchi L
    Clin Exp Dermatol; 2021 Jan; 46(1):96-102. PubMed ID: 32683727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the psychological burden of patients with hidradenitis suppurativa.
    Frings VG; Bauer B; Glöditzsch M; Goebeler M; Presser D
    Eur J Dermatol; 2019 Jun; 29(3):294-301. PubMed ID: 31145081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa.
    Miller I; Lynggaard CD; Lophaven S; Zachariae C; Dufour DN; Jemec GB
    Br J Dermatol; 2011 Aug; 165(2):391-8. PubMed ID: 21457202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
    Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
    J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Contribution of Malodour in Quality of Life of Patients With Hidradenitis Suppurativa.
    Alavi A; Farzanfar D; Lee RK; Almutairi D
    J Cutan Med Surg; 2018; 22(2):166-174. PubMed ID: 29231053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery combined with photodynamic therapy for the treatment of Hidradenitis Suppurativa: A report of 7 cases.
    Bu W; Xu X; Wang Y; Huang L; Zeng R; Chen X; Fang F
    Photodiagnosis Photodyn Ther; 2017 Jun; 18():46-49. PubMed ID: 28119142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hidradenitis suppurativa: Current and emerging treatments.
    Goldburg SR; Strober BE; Payette MJ
    J Am Acad Dermatol; 2020 May; 82(5):1061-1082. PubMed ID: 31604100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview and comparison of the clinical scores in hidradenitis suppurativa: A real-life clinical data.
    Daoud M; Suppa M; Benhadou F; Daxhelet M; Njimi H; White J; Jemec G; Del Marmol V
    Front Med (Lausanne); 2023; 10():1145152. PubMed ID: 37138732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.